$SCTL News

Last published 2y ago

2y agoSCTLCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.GlobeNewswireCLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- CoreRx, Inc. ("CoreRx") today announced that it has completed its acquisition of Societal CDMO, Inc. ("Societal CDMO") (NASDAQ:SCTL), a contract development and
2y agoSCTLCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.Business WireCoreRx, Inc. ("CoreRx") today announced that it has completed its acquisition of Societal CDMO, Inc. ("Societal CDMO") (NASDAQ:SCTL), a contract development and manufacturing organization dedicated to solving complex
2y agoEVRI FIXX GRPH SCTLKuehn Law Encourages FIXX, SCTL, EVRI, and GRPH Investors to Contact Law FirmGlobeNewswireNEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
2y agoSCTLSocietal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.GlobeNewswireSocietal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender
2y agoSCTLSocietal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug DevelopersGlobeNewswireAgreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process
2y agoSCTLSocietal CDMO Reports Inducement Grants for New StaffGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal CDMO", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
3y agoSCTLSocietal CDMO, Inc. (SCTL) Q3 2023 Earnings Call TranscriptEarnings Call Transcripts
3y agoSCTLSocietal CDMO Reports Third Quarter 2023 Financial ResultsGlobeNewswireRecorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate
3y agoSCTLSocietal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 2023GlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving
3y agoSCTLSocietal CDMO Reports Inducement Grants for New StaffGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal CDMO", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
3y agoSCTLSocietal CDMO to Participate in RBC Capital Markets Virtual CDMO ConferenceGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal CDMO" or "Societal", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving
3y agoSCTLSocietal CDMO Announces Corporate RestructuringGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal CDMO", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
3y agoSCTLSocietal CDMO Secures Project Expansion Agreements With Several Existing CustomersGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
3y agoSCTLSocietal CDMO Announces Closing of $8.3 Million Public Offering of Common StockGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal", NASDAQ:SCTL), a contract development and manufacturing organization ("CDMO") dedicated to solving complex formulation
3y agoSCTLSocietal CDMO Announces Pricing of $8.3 Million Public Offering of Common StockGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal", NASDAQ:SCTL), a contract development and manufacturing organization ("CDMO") dedicated to solving complex formulation
3y agoSCTLSocietal CDMO Announces Appointment of Matt Arens to Board of DirectorsGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation
3y agoSCTLSocietal CDMO Announces Proposed Public Offering of Common StockGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal", NASDAQ:SCTL), a contract development and manufacturing organization ("CDMO") dedicated to solving complex formulation
3y agoSCTLSocietal CDMO Reports Second Quarter 2023 Financial ResultsGlobeNewswireRecorded Q2 Revenue of $21.8 Million Signed Multiple New Business Agreements with New and Existing Customers Secured Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency; Allows Expansion
3y agoSCTLSocietal CDMO Reschedules Second Quarter 2023 Financial Results Reporting to August 14, 2023GlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving
3y agoSCTLSocietal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development MarketGlobeNewswireCompany Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25 Years of Manufacturing of Schedule 2 Products No Additional Investment Required to Support Clinical
3y agoSCTLSocietal CDMO Selected by Spinnaker Biosciences to Provide CDMO Services to Support Clinical Development of Novel Therapeutic CandidateGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., July 10, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal CDMO", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
3y agoSCTLSocietal CDMO Reports Inducement Grants for New StaffGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., July 07, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation
3y agoSCTLSocietal CDMO Signs Master Service Agreement With CivicaScript to Provide CDMO ServicesGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., June 29, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation
3y agoATOS SCTLSocietal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor ModulatorGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., May 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal CDMO", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
3y agoSCTLSocietal CDMO Reports First Quarter 2023 Financial ResultsGlobeNewswireRecorded Q1 Revenue of $21.5 Million Signed Multiple New Business Agreements with New and Existing Customers Granted FDA Approval for Manufacture of First Commercial Tablet Product Company to Host Webcast Today at
3y agoSCTLSocietal CDMO to Participate in RBC Capital Markets Global Healthcare ConferenceGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., May 09, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving
3y agoSCTLSocietal CDMO Selected by Xequel Bio to Provide CDMO Services to Support Ongoing Clinical Development of iNexin™GlobeNewswireSAN DIEGO and GAINESVILLE, Ga., May 08, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO), today announced that it has been
3y agoSCTLSocietal CDMO to Report Financial Results for First Quarter 2023 on May 10, 2023GlobeNewswireSAN DIEGO and GAINESVILLE, Ga., May 03, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving
3y agoCING CINGW SCTLCingulate Announces Successful Transfer of CTx-1301 (dexmethylphenidate) Proprietary PTR™ Manufacturing Processes to Societal CDMOGlobeNewswireKANSAS CITY, Kan., May 03, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to
3y agoSCTLSocietal CDMO Signs Multiple Project Expansion Agreements With Existing CustomersGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., April 12, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
3y agoSCTLSocietal CDMO Reports Inducement Grants for New StaffGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., April 06, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
3y agoSCTLSocietal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352GlobeNewswireSAN DIEGO and GAINESVILLE, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO), today announced that it has been
3y agoSCTLSocietal CDMO Announces U.S. FDA Approval for Manufacturing of Commercial Tablet at Gainesville, Georgia SiteGlobeNewswireSAN DIEGO, Calif. and GAINESVILLE, Ga., March 20, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to
3y agoSCTLSocietal CDMO to Participate at 35th Annual Roth ConferenceGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., March 03, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving
3y agoSCTLSocietal CDMO Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewswireRecorded Q4 Revenue of $24.3 Million, a 9% Increase Compared to Prior Year Period Clinical Trial Materials Development Business Grew by 58% in 2022; Significantly Expanded and Diversified Customer Base Executed
3y agoSCTLSocietal CDMO to Report Financial Results for Fourth Quarter and Year-End 2022 on March 1, 2023GlobeNewswireWebcast Scheduled for Wednesday, March 1, 2023, at 4:30 p.m. Eastern SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract
3y agoSCTLSocietal CDMO Highlights Growth of Existing Customer Business Through Signing of More Than $6 Million in Work Orders During Fourth Quarter of 2022GlobeNewswireExpansion in Scope of Projects Seen Across All CDMO Service Capabilities and Manufacturing Facilities; Addressing Evolving Customer Needs Through Customized Project Modifications Existing Customer Wins Supplement
3y agoSCTLSocietal CDMO Reports Inducement Grants for New StaffGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation
3y agoSCTLSocietal CDMO Completes Strategic Recast of Capital Structure Highlighted by Reduction and Refinancing of Outstanding DebtGlobeNewswireClosing of Three Separate Transformative Capital Financings, Including Two Significant Non-Dilutive Transactions, Generates Combined Gross Proceeds of More than $100 Million Which Reduce Outstanding Debt from $100
3y agoSCTLSocietal CDMO Announces Closing of $35.6 Million Concurrent Public OfferingsGlobeNewswireEXTON, Pa., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing
3y agoSCTLSocietal CDMO Announces Pricing of $35.6 Million Concurrent Public OfferingsGlobeNewswireEXTON, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing
3y agoSCTLSocietal CDMO Announces Proposed Concurrent Public Offerings of Common Stock and Preferred StockGlobeNewswireEXTON, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (("Societal", NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing
3y agoSCTLSocietal CDMO Advances Multi-Step Strategy to Recast Capital Structure and Strengthen Balance SheetGlobeNewswireSigns Agreement for $39 Million Sale and Leaseback Transaction with Tenet Equity; Proceeds to be Used to Pay Down Portion of Outstanding Debt Enters into up to $37.5 Million Credit Agreement with Royal Bank of Canada
3y agoCING CINGW SCTLCingulate Inc. Reports Third Quarter 2022 Financial Results and Provides Clinical and Business UpdateGlobeNewswirePhase 3 Trial Initiation for Lead ADHD Candidate CTx-1301 in December 2022 Executed Manufacturing Agreement with Societal CDMO 2022 Psych Congress Presentation Demonstrated Ability of Anxiety Candidate CTx-2103 to
4y agoSCTLSocietal CDMO Reports Third Quarter 2022 Financial ResultsGlobeNewswireRecorded Q3 Revenue of $21.6 Million, a 19% Increase Compared to Prior Year Period Entered into Real Estate Sales and Purchase Agreement Expected to Generate Proceeds of More than $9 Million Signed Highest Number of
4y agoSCTLSocietal CDMO to Report Financial Results for Third Quarter 2022 on November 9, 2022GlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving
4y agoSCTLSocietal CDMO Announces Signing of Multiple New CDMO Service AgreementsGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation
4y agoSCTLSocietal CDMO Reports Inducement Grants for New StaffGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation
4y agoSCTLSocietal CDMO Announces Signing of Multiple Agreements With New and Existing CustomersGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges pri
4y agoSCTLSocietal CDMO Appoints Elena Cant to Board of DirectorsGlobeNewswireSAN DIEGO and GAINESVILLE, Ga., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges pri